103 related articles for article (PubMed ID: 11211336)
21. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
[No Abstract] [Full Text] [Related]
22. Opportunistic pricing: a new scourge, a new call for action.
Proj Inf Perspect; 1998 Dec; (26):1-5. PubMed ID: 11366486
[TBL] [Abstract][Full Text] [Related]
23. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
[No Abstract] [Full Text] [Related]
24. Nonnucleoside reverse transcriptase inhibitors.
Murphy RL
AIDS Clin Care; 1997 Oct; 9(10):75-7, 79. PubMed ID: 11364757
[TBL] [Abstract][Full Text] [Related]
25. '96-'97 new drugs and the nominees for 1997 are...
Notes Undergr; 1997; (No 35):suppl 1-2. PubMed ID: 11364566
[TBL] [Abstract][Full Text] [Related]
26. Popping pills for life.
Focus; 1998 Feb; 13(3):5-6. PubMed ID: 11365169
[TBL] [Abstract][Full Text] [Related]
27. [Seropositivity. Antiretrovirus treatments].
Tubiana R
Soins; 1998; (622):19-23. PubMed ID: 9574066
[No Abstract] [Full Text] [Related]
28. HIV integrase inhibitors show potent activity in clinical trials.
Winslow DL
AIDS Alert; 2007 Jan; 22(1):10-1. PubMed ID: 17722343
[No Abstract] [Full Text] [Related]
29. Antiretroviral rounds. Putting resistance to work.
Daar ES; Elion R
AIDS Clin Care; 2004 Jul; 16(7):56, 60. PubMed ID: 15300926
[No Abstract] [Full Text] [Related]
30. Anti-HIV agents. Atazanavir and saquinavir.
TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
[No Abstract] [Full Text] [Related]
31. Anti-HIV drug update.
Proj Inf Perspect; 2000 Mar; (29):6-7. PubMed ID: 12769050
[TBL] [Abstract][Full Text] [Related]
32. Buffalo hump: what the experts suggest.
Piliero PJ; McComsey GA
AIDS Clin Care; 2004 Mar; 16(3):22-3. PubMed ID: 15119294
[No Abstract] [Full Text] [Related]
33. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
Wilkins E
J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
[No Abstract] [Full Text] [Related]
34. HIV treatment options.
Smith D
AIDS Treat News; 1998 May; (No 294):4-5. PubMed ID: 11365404
[TBL] [Abstract][Full Text] [Related]
35. Fosamprenavir: a new PI option. Interview by Craig Sterritt.
Nadler J
IAPAC Mon; 2004 Feb; 10(2):50-2. PubMed ID: 15106520
[No Abstract] [Full Text] [Related]
36. Controversies in current treatment guidelines.
Gazzard BG
J HIV Ther; 2008 Mar; 13(1):1-3. PubMed ID: 18953266
[No Abstract] [Full Text] [Related]
37. Rescue me.
Simmons P
Res Initiat Treat Action; 1998 Aug; 4(5):10. PubMed ID: 11365705
[TBL] [Abstract][Full Text] [Related]
38. WHO issues treatment guidelines for HIV/AIDS.
AIDS Policy Law; 2002 May; 17(9):1. PubMed ID: 12030233
[No Abstract] [Full Text] [Related]
39. Once-daily therapies.
Carey D
J HIV Ther; 2003 Feb; 8(1):7-11. PubMed ID: 12840708
[TBL] [Abstract][Full Text] [Related]
40. HIV: it's beginning to look like a chronic disease.
del Rio C
AIDS Clin Care; 2001 Sep; 13(9):82-3. PubMed ID: 11547601
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
